LLY

745.41

-0.55%↓

JNJ

153.49

+0.9%↑

UNH

320.87

+2.66%↑

ABBV

184.64

-0.12%↓

NVO

67.92

+1.91%↑

LLY

745.41

-0.55%↓

JNJ

153.49

+0.9%↑

UNH

320.87

+2.66%↑

ABBV

184.64

-0.12%↓

NVO

67.92

+1.91%↑

LLY

745.41

-0.55%↓

JNJ

153.49

+0.9%↑

UNH

320.87

+2.66%↑

ABBV

184.64

-0.12%↓

NVO

67.92

+1.91%↑

LLY

745.41

-0.55%↓

JNJ

153.49

+0.9%↑

UNH

320.87

+2.66%↑

ABBV

184.64

-0.12%↓

NVO

67.92

+1.91%↑

LLY

745.41

-0.55%↓

JNJ

153.49

+0.9%↑

UNH

320.87

+2.66%↑

ABBV

184.64

-0.12%↓

NVO

67.92

+1.91%↑

Search

PerkinElmer Inc

Open

SectorGezondheidszorg

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken

By Trading Economics

Inkomsten

-52M

42M

Verkoop

-65M

665M

K/W

Sectorgemiddelde

40.465

56.602

EPS

1.01

Dividendrendement

0.28

Winstmarge

6.354

Werknemers

11,000

EBITDA

-151M

72M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+25.22% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.28%

2.45%

Volgende Winsten

28 jul 2025

Volgende dividenddatum

8 aug 2025

Volgende Ex Dividend datum

18 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-2.5B

12B

Vorige openingsprijs

0

Vorige sluitingsprijs

0

Nieuwssentiment

By Acuity

38%

62%

147 / 382 Rangschikking in Healthcare

PerkinElmer Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 mei 2025, 20:40 UTC

Acquisities, Fusies, Overnames

FedEx Names CEO, Chairman for Planned Freight Spinoff

20 mei 2025, 00:00 UTC

Top Nieuws

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

19 mei 2025, 23:48 UTC

Marktinformatie

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19 mei 2025, 23:43 UTC

Marktinformatie

Gold Edges Lower on Possible Technical Correction -- Market Talk

19 mei 2025, 23:22 UTC

Top Nieuws

Crypto Billionaire Accused of Defrauding Creditors, Propelling Industry's 2022 Collapse -- WSJ

19 mei 2025, 22:33 UTC

Marktinformatie

Uranium Buyers Could Accelerate Restocking -- Market Talk

19 mei 2025, 22:16 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19 mei 2025, 22:16 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell Stake for CNY4.15B

19 mei 2025, 22:15 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell Stake to China Resources Land

19 mei 2025, 22:15 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q Rev $1.9B >TCOM

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q Adj EPS 82c >TCOM

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q EPS 84c >TCOM

19 mei 2025, 21:58 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

19 mei 2025, 21:58 UTC

Marktinformatie

Global Equities Roundup: Market Talk

19 mei 2025, 21:58 UTC

Marktinformatie

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19 mei 2025, 21:50 UTC

Top Nieuws
Winsten

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mei 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

19 mei 2025, 20:48 UTC

Top Nieuws

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19 mei 2025, 20:20 UTC

Top Nieuws

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19 mei 2025, 20:15 UTC

Acquisities, Fusies, Overnames

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19 mei 2025, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

19 mei 2025, 19:59 UTC

Top Nieuws

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19 mei 2025, 19:58 UTC

Marktinformatie

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19 mei 2025, 19:52 UTC

Marktinformatie

Imports Accelerate at Southern California Ports -- Market Talk

Peer Vergelijking

Prijswijziging

PerkinElmer Inc Prognose

Koersdoel

By TipRanks

25.22% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 118.08 USD  25.22%

Hoogste 135 USD

Laagste 100 USD

Gebaseerd op 14 Wall Street-analisten die 12-maands prijsdoelen bieden voor PerkinElmer Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

14 ratings

9

Buy

5

Hold

0

Sell

Sentiment

By Acuity

147 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.